妊娠期糖尿病中循环肾上腺髓质素升高及其对β细胞胰岛素生成受损的作用
该研究检测了糖耐量正常与妊娠期糖尿病孕妇血浆MR-proADM水平,并用人胰腺β细胞系评估肾上腺髓质素对胰岛素合成与分泌的影响。结果显示GDM孕妇MR-proADM显著升高,肾上腺髓质素剂量依赖性抑制β细胞胰岛素mRNA和分泌,该效应可被拮抗剂及PKA、Erk抑制剂阻断。
要点
- GDM孕妇血浆MR-proADM水平显著高于糖耐量正常孕妇。
- 肾上腺髓质素剂量依赖性抑制人β细胞胰岛素mRNA与分泌。
- 该抑制效应可被ADM22-52、KT5720和PD98059阻断,不被wortmannin阻断。
核心结论
- 妊娠期糖尿病孕妇循环肾上腺髓质素浓度升高。
- 肾上腺髓质素在体外抑制胰腺β细胞胰岛素合成与分泌。
- 循环肾上腺髓质素升高可能参与糖尿病妊娠中β细胞适应缺陷。
研究设计与样本
- 检测糖耐量正常孕妇(n=10)与妊娠期糖尿病孕妇(n=11)血浆MR-proADM水平。
- 人胰腺β细胞来源的β-Lox5细胞系经PDX1慢病毒载体转导后以不同剂量肾上腺髓质素处理。
- 检测β-Lox5细胞胰岛素、ADM及其受体组分mRNA和培养基胰岛素。
主要发现
- GDM组血浆MR-proADM水平显著高于NGT组。
- β-Lox5细胞表达胰岛素、ADM及其受体组分mRNA。
- PDX1转导与细胞间接触协同促进β-Lox5细胞胰岛素mRNA和分泌。
- 肾上腺髓质素剂量依赖性抑制β-Lox5细胞聚集体的胰岛素mRNA和分泌。
- 抑制效应被ADM22-52、KT5720和PD98059阻断,不被wortmannin阻断。
临床怎么用
- 循环肾上腺髓质素可能作为GDM中β细胞功能受损的候选标志物。
- 肾上腺髓质素拮抗剂可能改善β细胞功能,但尚需进一步临床验证。
局限性
- 血浆MR-proADM检测的孕妇样本量较小(NGT n=10,GDM n=11)。
- 肾上腺髓质素对胰岛素合成与分泌的影响仅在人β细胞系体外实验中评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Defective pancreatic β-cell adaptation in pregnancy plays an important role in the pathophysiology of gestational diabetes mellitus (GDM), but the molecular basis remains unclear. Objectives of this study were to determine if circulating levels of adrenomedullin (ADM) in women with GDM are elevated and to assess the effects of ADM on insulin synthesis and secretion by human pancreatic β-cells. DESIGN: A stable gene product of ADM precursor, midregional pro-adrenomedullin (MR-proADM), was measured in plasma of pregnant women with normal glucose tolerance (NGT, n = 10) or GDM (n = 11). The β-Lox5 cell line, derived from human pancreatic β-cells, was transduced with homeodomain transcription factor pancreatic-duodenal homeobox (PDX) factor 1 (PDX1) encoding lentiviral vector and treated with different doses of ADM. mRNA for insulin, ADM, and its receptor components in β-Lox5 cells and insulin in media were measured. RESULTS: Plasma MR-proADM levels were significantly higher in GDM compared with patients with NGT. Pancreatic β-Lox5 cells express mRNA for insulin, ADM, and its receptor components. PDX1 transduction and cell-cell contact synergistically promote β-Lox5 cells insulin mRNA and secretion. Furthermore, ADM dose-dependently inhibited mRNA and secretion of insulin in β-Lox5 cell aggregates. These inhibitory effects were blocked by ADM antagonist ADM22-52, cAMP-dependent protein kinase A inhibitor KT5720, and Erk inhibitor PD98059, but not by PI-3K the inhibitor wortmannin. CONCLUSIONS: Circulating ADM concentrations were elevated in pregnant women with GDM. ADM suppresses insulin synthesis and secretion by pancreatic β-cells in vitro. Thus, increased circulating ADM may contribute to the defective adaptation of β-cells in diabetic pregnancies, and blockade of ADM actions with its antagonists may improve β-cell functions.
引用
- Dong Y, Banadakoppa M, Chauhan M, et al. Circulating Adrenomedullin Is Elevated in Gestational Diabetes and Its Role in Impaired Insulin Production by β-Cells. J Clin Endocrinol Metab. 2019. PMID: 30383252. doi:10.1210/jc.2018-01119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。